Facial erythema of rosacea - aetiology, different pathophysiologies and treatment options

Rosacea is a common chronic skin condition that displays a broad diversity of clinical manifestations. Although the pathophysiological mechanisms of the four subtypes are not completely elucidated, the key elements often present are augmented immune responses of the innate and adaptive immune system...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Steinhoff, Martin (VerfasserIn) , Schmelz, Martin (VerfasserIn) , Schauber, Jürgen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Acta dermato-venereologica
Year: 2015, Jahrgang: 96, Heft: 5, Pages: 579-586
ISSN:1651-2057
DOI:10.2340/00015555-2335
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.2340/00015555-2335
Verlag, kostenfrei, Volltext: http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-2335
Volltext
Verfasserangaben:Martin Steinhoff, Martin Schmelz and Jürgen Schauber
Beschreibung
Zusammenfassung:Rosacea is a common chronic skin condition that displays a broad diversity of clinical manifestations. Although the pathophysiological mechanisms of the four subtypes are not completely elucidated, the key elements often present are augmented immune responses of the innate and adaptive immune system, and neurovascular dysregulation. The most common primary feature of all cutaneous subtypes of rosacea is transient or persistent facial erythema. Perilesional erythema of papules or pustules is based on the sustained vasodilation and plasma extravasation induced by the inflammatory infiltrates. In contrast, transient erythema has rapid kinetics induced by trigger factors independent of papules or pustules. Amongst the current treatments for facial erythema of rosacea, only the selective α2-adrenergic receptor agonist brimonidine 0.33% topical gel (Mirvaso®) is approved. This review aims to discuss the potential causes, different pathophysiologies and current treatment options to address the unmet medical needs of patients with facial erythema of rosacea.
Beschreibung:Gesehen am 11.07.2019
Epub ahead of print Dec 30, 2015
Beschreibung:Online Resource
ISSN:1651-2057
DOI:10.2340/00015555-2335